Quest Diagnostics IncorporatedDGXNYSE
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank86
5Y CAGR-10.9%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
-10.9%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 49.50% |
| 2024 | 5.21% |
| 2023 | -34.25% |
| 2022 | -28.20% |
| 2021 | 15.31% |
| 2020 | 88.26% |
| 2019 | 3.18% |
| 2018 | -11.48% |
| 2017 | 18.94% |
| 2016 | 41.86% |